106 related articles for article (PubMed ID: 29731984)
1. Hormone replacement therapy decreases the risk of tinnitus in menopausal women: a nationwide study.
Chen HC; Chung CH; Chen VCF; Wang YC; Chien WC
Oncotarget; 2018 Apr; 9(28):19807-19816. PubMed ID: 29731984
[TBL] [Abstract][Full Text] [Related]
2. Hormone therapy and risk of venous thromboembolism among postmenopausal women in Taiwan - a 10-year nationwide population-based study.
Lee CH; Cheng CL; Kao Yang YH; Lin LJ
Circ J; 2015; 79(5):1107-14. PubMed ID: 25753572
[TBL] [Abstract][Full Text] [Related]
3. Is hormone replacement therapy in post-menopausal women associated with a reduced risk of oesophageal cancer?
Menon S; Nightingale P; Trudgill N
United European Gastroenterol J; 2014 Oct; 2(5):374-82. PubMed ID: 25360315
[TBL] [Abstract][Full Text] [Related]
4. The Risk of Breast Cancer in Women Using Menopausal Hormone Replacement Therapy in Taiwan.
Liu JY; Chen TJ; Hwang SJ
Int J Environ Res Public Health; 2016 May; 13(5):. PubMed ID: 27187426
[TBL] [Abstract][Full Text] [Related]
5. Hormone Replacement Therapy, Breast Cancer Risk Factors, and Breast Cancer Risk: A Nationwide Population-Based Cohort.
Yoo TK; Han KD; Kim D; Ahn J; Park WC; Chae BJ
Cancer Epidemiol Biomarkers Prev; 2020 Jul; 29(7):1341-1347. PubMed ID: 32299849
[TBL] [Abstract][Full Text] [Related]
6. Association of perceived tinnitus with duration of hormone replacement therapy in Korean postmenopausal women: a cross-sectional study.
Lee SS; Han KD; Joo YH
BMJ Open; 2017 Jul; 7(7):e013736. PubMed ID: 28698314
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy in Germany: determinants and possible health-related outcomes. Results of National Health Surveys from 1984 to 1999.
Du Y; Melchert HU; Schäfer-Korting M
Maturitas; 2005; 52(3-4):223-34. PubMed ID: 16040212
[TBL] [Abstract][Full Text] [Related]
8. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
Madalinska JB; van Beurden M; Bleiker EM; Valdimarsdottir HB; Hollenstein J; Massuger LF; Gaarenstroom KN; Mourits MJ; Verheijen RH; van Dorst EB; van der Putten H; van der Velden K; Boonstra H; Aaronson NK
J Clin Oncol; 2006 Aug; 24(22):3576-82. PubMed ID: 16877724
[TBL] [Abstract][Full Text] [Related]
9. Effect of hormone replacement therapy on hemostatic variables in post-menopausal women.
Al-Farra HM; Al-Fahoum SK; Tabbaa MA
Saudi Med J; 2005 Dec; 26(12):1930-5. PubMed ID: 16380775
[TBL] [Abstract][Full Text] [Related]
10. The effects of hormone replacement therapy on postmenopausal breast cancer biology and survival.
Sener SF; Winchester DJ; Winchester DP; Du H; Barrera E; Bilimoria M; Krantz S; Rabbitt S
Am J Surg; 2009 Mar; 197(3):403-7. PubMed ID: 19245923
[TBL] [Abstract][Full Text] [Related]
11. Use of hormone replacement therapy by menopausal women in six family-practice teaching clinics in Israel.
Vinker S; Kaplan B; Yaphe J; Cohen O; Shumla V; Shapira G; Shofty I; Kitai E
Climacteric; 2003 Mar; 6(1):75-80. PubMed ID: 12725667
[TBL] [Abstract][Full Text] [Related]
12. The effect of prothrombotic blood abnormalities on risk of deep vein thrombosis in users of hormone replacement therapy: a prospective case-control study.
Douketis JD; Julian JA; Crowther MA; Kearon C; Bates SM; Barone M; Piovella F; Middeldorp S; Prandoni P; Johnston M; Costantini L; Ginsberg JS
Clin Appl Thromb Hemost; 2011; 17(6):E106-13. PubMed ID: 21159708
[TBL] [Abstract][Full Text] [Related]
13. The Association between Hormone Replacement Therapy and Gastroparesis in Post-Menopausal Women: A Worldwide Database Analysis.
Khalil J; Hill H; Kaelber D; Song G
J Pers Med; 2024 Feb; 14(3):. PubMed ID: 38541017
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort - a cross-sectional analysis.
Waaseth M; Bakken K; Dumeaux V; Olsen KS; Rylander C; Figenschau Y; Lund E
BMC Womens Health; 2008 Jan; 8():1. PubMed ID: 18194511
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy and mammographic screening outcomes in Western Australia.
Crouchley K; Wylie E; Khong E
J Med Screen; 2006; 13(2):93-7. PubMed ID: 16792833
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
Windler E; Zyriax BC; Eidenmüller B; Boeing H
Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
[TBL] [Abstract][Full Text] [Related]
17. Low biologic aggressiveness in breast cancer in women using hormone replacement therapy.
Holli K; Isola J; Cuzick J
J Clin Oncol; 1998 Sep; 16(9):3115-20. PubMed ID: 9738583
[TBL] [Abstract][Full Text] [Related]
18. Factors predicting current use of hormone replacement therapy among menopausal Jewish women in Israel. The National Women's Health Interview Survey, 1998.
Merom D; Ifrah A; Cohen-Manheim I; Chinich A; Green MS
Isr Med Assoc J; 2002 Sep; 4(9):671-6. PubMed ID: 12440227
[TBL] [Abstract][Full Text] [Related]
19. Risk of depression following uterine cancer: A nationwide population-based study.
Chen CY; Yang YH; Lee CP; Wang TY; Cheng BH; Huang YC; Chen PC; Liang SH; Dewey M; Chen VC
Psychooncology; 2017 Nov; 26(11):1770-1776. PubMed ID: 28029721
[TBL] [Abstract][Full Text] [Related]
20. Hormone Replacement Therapy and Psoriasis Risk: A Nationwide Population-Based Cohort Study.
Go GM; Oh HJ; Han K; Kim YH; Lee HJ; Lee JH
J Korean Med Sci; 2023 Dec; 38(49):e377. PubMed ID: 38111280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
